ConductScience.org, home

Paper42907643PubMed

Analytical Insights and Biomedical Applications of Homing Penetrating Peptides in Cancer.

Darie-Ion L and 2 others. Adv Exp Med Biol, 2026.

Cite this record

ConductScience Library. Analytical Insights and Biomedical Applications of Homing Penetrating Peptides in Cancer. Papers, record 42907643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42907643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Analytical Insights and Biomedical Applications of Homing Penetrating Peptides in Cancer.
Journal
Adv Exp Med Biol
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-22

Source PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Darie-Ion LLaura
2Ciobanasu CCorina
3Petre BABrindusa Alina

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References74

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111734621Estrogen receptors and proliferation markers in primary and recurrent breast cancer.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11734621PubMed
216301830VEGF as a key mediator of angiogenesis in cancer.Oncology2005https://conductscience.org/library/papers/16301830PubMed
322846215Permissive role of endothelin receptors in tumor metastasis.Life Sci2012https://conductscience.org/library/papers/22846215PubMed
49496384Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials.Ann Oncol1997https://conductscience.org/library/papers/9496384PubMed
528799536Estrogen receptor (ESR1) mutation in bone metastases from breast cancer.Mod Pathol2018https://conductscience.org/library/papers/28799536PubMed
633543454Homing Peptides for Cancer Therapy.Adv Exp Med Biol2021https://conductscience.org/library/papers/33543454PubMed
728544932Vascular-homing peptides for cancer therapy.Biomed Pharmacother2017https://conductscience.org/library/papers/28544932PubMed
824533809Tumor homing peptides as molecular probes for cancer therapeutics, diagnostics and theranostics.Curr Med Chem2014https://conductscience.org/library/papers/24533809PubMed
937389978Cell Penetrating Peptides: Classification, Mechanisms, Methods of Study, and Applications.ChemMedChem2023https://conductscience.org/library/papers/37389978PubMed
1028209404Cell-Penetrating Peptides: From Basic Research to Clinics.Trends Pharmacol Sci2017https://conductscience.org/library/papers/28209404PubMed
1138892406Tumor-Homing Peptides as Crucial Component of Magnetic-Based Delivery Systems: Recent Developments and Pharmacoeconomical Perspective.Int J Mol Sci2024https://conductscience.org/library/papers/38892406PubMed
1240672665Advancing Cancer-Targeted Nanotherapies with Tumor Homing Peptides.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/40672665PubMed
1323986882Tumor-penetrating peptides.Front Oncol2013https://conductscience.org/library/papers/23986882PubMed
1419833724Translocation and endocytosis for cell-penetrating peptide internalization.J Biol Chem2009https://conductscience.org/library/papers/19833724PubMed
1522472979Do cell-penetrating peptides actually "penetrate" cellular membranes?Mol Ther2012https://conductscience.org/library/papers/22472979PubMed
1640856125Cell-penetrating peptides as facilitators of cargo-specific nanocarrier-based drug delivery.Nanoscale2025https://conductscience.org/library/papers/40856125PubMed
1738105200Cell-Penetrating Peptides as Vehicles for Delivery of Therapeutic Nucleic Acids. Mechanisms and Application in Medicine.Biochemistry (Mosc)2023https://conductscience.org/library/papers/38105200PubMed
1837631307Recent Advances of Cell-Penetrating Peptides and Their Application as Vectors for Delivery of Peptide and Protein-Based Cargo Molecules.Pharmaceutics2023https://conductscience.org/library/papers/37631307PubMed
1927713270Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy.Pharmaceuticals (Basel)2010https://conductscience.org/library/papers/27713270PubMed
2033224505Ultralong tumor retention of theranostic nanoparticles with short peptide-enabled active tumor homing.Mater Horiz2019https://conductscience.org/library/papers/33224505PubMed

See all 74 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42907643

GET https://conductscience.org/api/papers/v1/42907643/references?page=2